'Pharma bro' Martin Shkreli heads into fraud trial
June 26, 2017 at 06:00 AM EDT
NEW YORK, June 26 (Reuters) - Martin Shkreli, the pharmaceutical entrepreneur vilified as the "pharma bro" for raising the price of a life-saving drug by 5,000 percent, will go on trial on Monday for what U.S. prosecutors called a Ponzi-like scheme at his former hedge fund and a drug company he once ran.